AIDS-related Diffuse Small Cleaved Cell Lymphoma: Clinical Trials

6 trials for AIDS-related Diffuse Small Cleaved Cell Lymphoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 1 withdrawn. 2 Not applicable, 2 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable2Completed 1, Withdrawn 1
Phase 12Completed 2
Phase 22Completed 2

Follow AIDS-related Diffuse Small Cleaved Cell Lymphoma: new trials by email Literature Review of AIDS-related Diffuse Small Cleaved Cell Lymphoma trials Research Report on AIDS-related Diffuse Small Cleaved Cell Lymphoma

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Intravenous Chemotherapy or Oral Chemotherapy in Treating Patients With Previously Untreated Stage III-IV HIV-Associated Non-Hodgkin Lymphoma
cyclophosphamide, doxorubicin hydrochloride, vincristine sulfate - AIDS-related Diffuse Large Cell Lymphoma, AIDS-related Diffuse Mixed Cell Lymphoma
Phase 2CompletedAIDS Malignancy Consortium72016-09-152022-10-10
Genetically Modified Peripheral Blood Stem Cell Transplant in Treating Patients With HIV-Associated Non-Hodgkin or Hodgkin Lymphoma
carmustine, cytarabine, melphalan - Adult Nasal Type Extranodal NK/T-cell Lymphoma, AIDS-related Diffuse Large Cell Lymphoma
Not applicableWithdrawnFred Hutchinson Cancer Center2015-02-012015-05-07
RO4929097 and Capecitabine in Treating Patients With Refractory Solid Tumors
gamma-secretase/Notch signalling pathway inhibitor RO4929097, capecitabine, laboratory biomarker analysis - Adult Grade III Lymphomatoid Granulomatosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma
Phase 1CompletedNational Cancer Institute (NCI)302010-06-012014-11-07
Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy
sunitinib malate, pharmacological study, laboratory biomarker analysis - Accelerated Phase Chronic Myelogenous Leukemia, Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome
Phase 1CompletedNational Cancer Institute (NCI)422009-08-012014-03-17
Topotecan Hydrochloride in Treating Children With Meningeal Cancer That Has Not Responded to Previous Treatment
topotecan hydrochloride, laboratory biomarker analysis - AIDS-related Diffuse Large Cell Lymphoma, AIDS-related Diffuse Mixed Cell Lymphoma
Phase 2CompletedNational Cancer Institute (NCI)772000-04-012013-02-21
Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer
fludarabine phosphate, total-body irradiation, peripheral blood stem cell transplantation - Accelerated Phase Chronic Myelogenous Leukemia, Acute Undifferentiated Leukemia
Not applicableCompletedFred Hutchinson Cancer Center51999-11-012017-05-24

Narrower conditions

Burkitt Lymphoma (5)  ·  Lymphoma, Large B-Cell, Diffuse (5)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (5)  ·  Hodgkin Disease (4)  ·  Immunoblastic Lymphadenopathy (4)  ·  Intraocular Lymphoma (4)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (4)  ·  Lymphoma, B-Cell, Marginal Zone (4)  ·  Lymphoma, Extranodal NK-T-Cell (4)  ·  Lymphoma, Follicular (4)  ·  Lymphoma, Large-Cell, Anaplastic (4)  ·  Lymphoma, Large-Cell, Immunoblastic (4)  ·  Lymphoma, Mantle-Cell (4)  ·  Lymphoma, Non-Hodgkin (4)  ·  Lymphoma, T-Cell, Cutaneous (4)

Broader conditions

Hemic and Lymphatic Diseases (6)  ·  Immune System Diseases (6)  ·  Immunoproliferative Disorders (6)  ·  Lymphatic Diseases (6)  ·  Lymphoma, B-Cell (6)  ·  Lymphoproliferative Disorders (6)  ·  Neoplasms (6)  ·  Neoplasms by Histologic Type (6)  ·  DNA Virus Infections (5)  ·  Disease Attributes (5)  ·  Epstein-Barr Virus Infections (5)  ·  Hematologic Diseases (5)  ·  Herpesviridae Infections (5)  ·  Infections (5)  ·  Leukemia, Lymphoid (5)

Interventions

Etoposide (2)  ·  Peripheral Blood Stem Cell Transplantation (2)  ·  2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide (1)  ·  Capecitabine (1)  ·  Carmustine (1)  ·  Cyclophosphamide (1)  ·  Cyclosporine (1)  ·  Cytarabine (1)  ·  Doxorubicin (1)  ·  Lomustine (1)  ·  Melphalan (1)  ·  Mycophenolic Acid (1)  ·  O(6)-benzylguanine (1)  ·  Prednisone (1)  ·  Procarbazine (1)

Sponsors

National Cancer Institute (NCI) (3)  ·  Fred Hutchinson Cancer Center (2)  ·  AIDS Malignancy Consortium (1)

Countries

United States (5)  ·  Canada (1)  ·  Kenya (1)  ·  Zimbabwe (1)

Top investigators

Ann Woolfrey (2)  ·  John Deeken (1)  ·  Noelle LoConte (1)  ·  Robert Strother (1)  ·  Susan Blaney (1)

Results publications

PMID 18698002, PMID 22259028, PMID 24474568

NIH funding

P30CA015704 (2), U01CA121947 (2), P01CA018029 (1), P30CA014520 (1), U01CA062491 (1), U01CA132123 (1), U10CA098543 (1)